Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma

被引:0
作者
Benjamin N. Schmeusser
Adil A. Ali
Florian J. Fintelmann
Jose M. Garcia
Grant R. Williams
Viraj A. Master
Sarah P. Psutka
机构
[1] Emory University School of Medicine,Department of Urology
[2] Massachusetts General Hospital,Department of Radiology
[3] VA Puget Sound Health Care System,Geriatric Research, Education and Clinical Center (GRECC)
[4] University of Washington School of Medicine,Department of Medicine, Division of Gerontology & Geriatric Medicine
[5] University of Alabama at Birmingham,Institute for Cancer Outcomes and Survivorship
[6] University of Alabama at Birmingham,Division of Hematology and Oncology, Department of Medicine
[7] Winship Cancer Institute,Department of Urology
[8] Emory University,Fred Hutchinson Cancer Center
[9] University of Washington,undefined
[10] University of Washington,undefined
来源
Current Urology Reports | 2023年 / 24卷
关键词
Sarcopenia; Inflammation; Body composition; Skeletal muscle; Renal cell carcinoma (RCC); Prognostic factor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:317 / 334
页数:17
相关论文
共 50 条
  • [21] Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells
    Zhao, Man
    Duan, Xiaoling
    Han, Xin
    Wang, Jinfeng
    Han, Guangjie
    Mi, Lili
    Shi, Jianfei
    Li, Ning
    Yin, Xiaolei
    Hou, Jiaojiao
    Yin, Fei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study
    Ueki, Hideto
    Hara, Takuto
    Okamura, Yasuyoshi
    Bando, Yukari
    Terakawa, Tomoaki
    Furukawa, Junya
    Harada, Kenichi
    Nakano, Yuzo
    Fujisawa, Masato
    INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (04) : 415 - 424
  • [23] Sarcopenia predicts prognosis of patients with renal cell carcinoma: A systematic review and meta-analysis
    Hu, Xu
    Liao, Du-Wu
    Yang, Zhi-Qiang
    Yang, Wei-Xiao
    Xiong, San-Chao
    Li, Xiang
    INTERNATIONAL BRAZ J UROL, 2020, 46 (05): : 705 - 715
  • [24] Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinoma
    Schmeusser, Benjamin N.
    Patil, Dattatraya H.
    Midenberg, Eric
    Higgins, Michelle I.
    Zaldumbide, Joel
    Martini, Dylan J.
    Steele, Sean
    Williams, Milton
    Nabavizadeh, Reza
    Psutka, Sarah P.
    Ogan, Kenneth
    Bilen, Mehmet Asim
    Master, Vraj A.
    DATA IN BRIEF, 2022, 45
  • [25] Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker
    Schmeusser, Benjamin N.
    Biermann, Henry
    Nicaise, Edouard H.
    Ali, Adil A.
    Patil, Dattatraya H.
    Midenberg, Eric
    Helman, Talia
    Armas-Phan, Manuel
    Nabavizadeh, Reza
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Bilen, Mehmet A.
    Psutka, Sarah P.
    Ogan, Kenneth
    Master, Viraj A.
    ONCOLOGIST, 2023, : e1219 - e1229
  • [26] Systemic immune inflammation index is a promising non-invasive marker for the prognosis of the patients with localized renal cell carcinoma
    Emin Ozbek
    Huseyin Besiroglu
    Kutan Ozer
    Mustafa Ozan Horsanali
    Sacit Nuri Gorgel
    International Urology and Nephrology, 2020, 52 : 1455 - 1463
  • [27] External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model
    Chrom, Pawel
    Zolnierek, Jakub
    Bodnar, Lubomir
    Stec, Rafal
    Szczylik, Cezary
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (05) : 526 - 532
  • [28] Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma
    Erul, Enes
    Guven, Deniz C.
    Ozbay, Yakup
    Altunbulak, Ahmet Y.
    Kahvecioglu, Alper
    Ercan, Fatih
    Yesil, Muhammed F.
    Ucdal, Mete T.
    Cengiz, Mustafa
    Yazici, Gozde
    Kuscu, Oguz
    Suslu, Nilda
    Gullu, Ibrahim
    Onur, Mehmet R.
    Aksoy, Sercan
    BIOMARKERS IN MEDICINE, 2023, 17 (02) : 87 - 99
  • [29] External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model
    Pawel Chrom
    Jakub Zolnierek
    Lubomir Bodnar
    Rafal Stec
    Cezary Szczylik
    International Journal of Clinical Oncology, 2019, 24 : 526 - 532
  • [30] Systemic immune inflammation index is a promising non-invasive marker for the prognosis of the patients with localized renal cell carcinoma
    Ozbek, Emin
    Besiroglu, Huseyin
    Ozer, Kutan
    Horsanali, Mustafa Ozan
    Gorgel, Sacit Nuri
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (08) : 1455 - 1463